欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/V/0155/001
药品名称Exagon 400 400 mg/ml solution for injection
活性成分
    • pentobarbital 400.0 mg
剂型Solution for injection
上市许可持有人Richter Pharma AG, Feldgasse 19, 4600 Wels, Austria
参考成员国 - 产品名称Germany (DE)
Exagon
互认成员国 - 产品名称
    • Denmark (DK)
      Exagon Vet.
    • Iceland (IS)
      Exagon vet. 400 mg/ml Stungulyf, lausn
    • Austria (AT)
      Exagon 400 mg/ml Injektionslösung für Tiere
    • France (FR)
      EXAGON 400 MG/ML SOLUTION INJECTABLE (13593)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Exagon vet
    • Finland (FI)
    • Poland (PL)
      Exagon 400 mg/ml solution for injection
    • Latvia (LV)
      Exagon 400
    • Lithuania (LT)
      Exagon 400 mg/ml injekcinis tirpalas
    • Estonia (EE)
      Exagon
    • Czechia (CZ)
      Exagon 400 mg/ml injekční roztok
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
许可日期2014/01/29
最近更新日期2021/10/20
药物ATC编码
    • QN51AA01 pentobarbital
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase